1
|
Macagno N, Kervarrec T, Thanguturi S, Sohier P, Pissaloux D, Mescam L, Jullie ML, Frouin E, Osio A, Faisant M, Le Loarer F, Cribier B, Calonje E, Luna EVE, Massi D, Goto K, Nishida H, Paindavoine S, Houlier A, Tantot J, Benzerdjeb N, Tirode F, De la Fouchardière A, Battistella M. SOX10-Internal Tandem Duplications and PLAG1 or HMGA2 Fusions Segregate Eccrine-Type and Apocrine-Type Cutaneous Mixed Tumors. Mod Pathol 2024; 37:100430. [PMID: 38266920 DOI: 10.1016/j.modpat.2024.100430] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/31/2023] [Revised: 12/26/2023] [Accepted: 01/16/2024] [Indexed: 01/26/2024]
Abstract
Cutaneous mixed tumors exhibit a wide morphologic diversity and are currently classified into apocrine and eccrine types based on their morphologic differentiation. Some cases of apocrine-type cutaneous mixed tumors (ACMT), namely, hyaline cell-rich apocrine cutaneous mixed tumors (HCR-ACMT) show a prominent or exclusive plasmacytoid myoepithelial component. Although recurrent fusions of PLAG1 have been observed in ACMT, the oncogenic driver of eccrine-type cutaneous mixed tumors (ECMT) is still unknown. The aim of the study was to provide a comprehensive morphologic, immunohistochemical, and molecular characterization of these tumors. Forty-one cases were included in this study: 28 cases of ACMT/HCR-ACMT and 13 cases of ECMT. After morphologic and immunohistochemical characterization, all specimens were analyzed by RNA sequencing. By immunohistochemistry, all cases showed expression of SOX10, but only ACMT/HCR-ACMT showed expression of PLAG1 and HMGA2. RNA sequencing confirmed the presence of recurrent fusion of PLAG1 or HMGA2 in all cases of ACMT/HCR-ACMT, with a perfect correlation with PLAG1/HMGA2 immunohistochemical status, and revealed internal tandem duplications of SOX10 (SOX10-ITD) in all cases of ECMT. Although TRPS1::PLAG1 was the most frequent fusion, HMGA2::WIF1 and HMGA2::NFIB were detected in ACMT cases. Clustering analysis based on gene expression profiling of 110 tumors, including numerous histotypes, showed that ECMT formed a distinct group compared with all other tumors. ACMT, HCR-ACMT, and salivary gland pleomorphic adenoma clustered together, whereas myoepithelioma with fusions of EWSR1, FUS, PBX1, PBX3, POU5F1, and KLF17 formed another cluster. Follow-up showed no evidence of disease in 23 cases across all 3 tumor types. In conclusion, our study demonstrated for the first time SOX10-ITD in ECMT and HMGA2 fusions in ACMT and further refined the prevalence of PLAG1 fusions in ACMT. Clustering analyses revealed the transcriptomic distance between these different tumors, especially in the heterogenous group of myoepitheliomas.
Collapse
Affiliation(s)
- Nicolas Macagno
- CARADERM, French Network of Rare Skin Cancers, Lille, France; Department of Pathology, APHM, Timone, Marseille, France; Aix Marseille University, INSERM, MMG, Marseille, France.
| | - Thibault Kervarrec
- CARADERM, French Network of Rare Skin Cancers, Lille, France; Department of Pathology, Université de Tours, Centre Hospitalier Universitaire de Tours, Tours, France; "Biologie des infections à polyomavirus" team, UMR INRA ISP 1282, Université de Tours, Tours, France
| | | | - Pierre Sohier
- Department of Pathology, Hôpital Cochin, AP-HP. Centre-Université Paris Cité, Paris, France
| | - Daniel Pissaloux
- Department of Biopathology, Centre Léon Bérard, Lyon, France; Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Equipe Labellisée Ligue contre le Cancer, Lyon, France
| | - Lenaïg Mescam
- Department of Biopathology, Paoli-Calmettes Institute, Marseille, France
| | - Marie-Laure Jullie
- Department of Pathology, University Hospital of Bordeaux, Bordeaux, France
| | - Eric Frouin
- Department of Pathology, University Hospital of Poitiers, University of Poitiers, LITEC, Poitiers, France
| | - Amelie Osio
- National Center of Dermatopathology, Paris-la Roquette, Ivry, France; Department of Pathology, HCL Lyon-Sud Hospital, Lyon, France
| | | | - François Le Loarer
- Department of Biopathology, Bergonié Institute, Bordeaux, France; Bordeaux Institute of Oncology, BRIC U1312, INSERM, Université de Bordeaux, Institut Bergonié, Bordeaux, France
| | - Bernard Cribier
- Department of Dermatology, University of Strasbourg, Strasbourg, France
| | - Eduardo Calonje
- Department of Dermatopathology, St John's institute of Dermatology, Guy's and St Thomas' NHS trust, London, United Kingdom
| | - Evelyn Vanesa Erazo Luna
- Department of Dermatopathology, St John's institute of Dermatology, Guy's and St Thomas' NHS trust, London, United Kingdom
| | - Daniela Massi
- Section of Pathology, Department of Health Sciences, University of Florence, Florence, Italy
| | - Keisuke Goto
- Department of Diagnostic Pathology, Faculty of Medicine, Oita, Japan
| | - Haruto Nishida
- Department of Diagnostic Pathology, Faculty of Medicine, Oita, Japan
| | | | - Aurelie Houlier
- Department of Biopathology, Centre Léon Bérard, Lyon, France
| | - Juliet Tantot
- Department of Pathology, HCL Lyon-Sud Hospital, Lyon, France
| | | | - Franck Tirode
- Department of Biopathology, Centre Léon Bérard, Lyon, France; Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Equipe Labellisée Ligue contre le Cancer, Lyon, France
| | - Arnaud De la Fouchardière
- Department of Biopathology, Centre Léon Bérard, Lyon, France; Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Equipe Labellisée Ligue contre le Cancer, Lyon, France
| | - Maxime Battistella
- CARADERM, French Network of Rare Skin Cancers, Lille, France; Department of Pathology, AP-HP Hospital Saint-Louis, INSERM U976, Université Paris Cité, Paris, France
| |
Collapse
|
2
|
Kervarrec T, Appenzeller S, Tallet A, Jullie ML, Sohier P, Guillonneau F, Rütten A, Berthon P, Le Corre Y, Hainaut-Wierzbicka E, Blom A, Beneton N, Bens G, Nardin C, Aubin F, Dinulescu M, Visée S, Herfs M, Touzé A, Guyétant S, Samimi M, Houben R, Schrama D. Detection of wildtype Merkel cell polyomavirus genomic sequence and VP1 transcription in a subset of Merkel cell carcinoma. Histopathology 2024; 84:356-368. [PMID: 37830288 DOI: 10.1111/his.15068] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/20/2023] [Revised: 09/16/2023] [Accepted: 09/24/2023] [Indexed: 10/14/2023]
Abstract
AIMS Merkel cell carcinoma (MCC) is frequently caused by the Merkel cell polyomavirus (MCPyV). Characteristic for these virus-positive (VP) MCC is MCPyV integration into the host genome and truncation of the viral oncogene Large T antigen (LT), with full-length LT expression considered as incompatible with MCC growth. Genetic analysis of a VP-MCC/trichoblastoma combined tumour demonstrated that virus-driven MCC can arise from an epithelial cell. Here we describe two further cases of VP-MCC combined with an adnexal tumour, i.e. one trichoblastoma and one poroma. METHODS AND RESULTS Whole-genome sequencing of MCC/trichoblastoma again provided evidence of a trichoblastoma-derived MCC. Although an MCC-typical LT-truncating mutation was detected, we could not determine an integration site and we additionally detected a wildtype sequence encoding full-length LT. Similarly, Sanger sequencing of the combined MCC/poroma revealed coding sequences for both truncated and full-length LT. Moreover, in situ RNA hybridization demonstrated expression of a late region mRNA encoding the viral capsid protein VP1 in both combined as well as in a few cases of pure MCC. CONCLUSION The data presented here suggest the presence of wildtype MCPyV genomes and VP1 transcription in a subset of MCC.
Collapse
Affiliation(s)
- Thibault Kervarrec
- Department of Pathology, Université de Tours, Centre Hospitalier Universitaire de Tours, Tours, France
- "Biologie des Infections à Polyomavirus" Team, UMR INRAE ISP 1282, Université de Tours, Tours, France
| | - Silke Appenzeller
- Comprehensive Cancer Center Mainfranken, University Hospital of Würzburg, Würzburg, Germany
| | - Anne Tallet
- Platform of Somatic Tumor Molecular Genetics, Université de Tours, Centre Hospitalier Universitaire de Tours, Tours, France
| | - Marie-Laure Jullie
- Department of Pathology, Hôpital Haut-Lévêque, CHU de Bordeaux, CARADERM Network, Pessac, France
| | - Pierre Sohier
- Faculté de Médecine, Université Paris Cité, Paris, France
- Department of Pathology, Hôpital Cochin, AP-HP.Centre-Université Paris Cité, Paris, France
| | - Francois Guillonneau
- 3P5 Proteomics, Hôpital Cochin, AP-HP, Centre-Université Paris Cité, Paris, France
| | | | - Patricia Berthon
- "Biologie des Infections à Polyomavirus" Team, UMR INRAE ISP 1282, Université de Tours, Tours, France
| | - Yannick Le Corre
- Dermatology Department, LUNAM Université, CHU Angers, Angers, France
| | | | - Astrid Blom
- Department of General and Oncologic Dermatology, CARADERM Network Ambroise-Paré hospital, APHP & Research Unit EA 4340, University of Versailles-Saint-Quentin-en-Yvelines, Paris-Saclay University, Boulogne-Billancourt, France
| | | | - Guido Bens
- Dermatology Department, CHR d'Orléans, Orléans, France
- Dermatology Department, CH de Blois, Blois, France
| | - Charline Nardin
- Dermatology Department, Inserm 1098, Université de Franche Comté, CHU Besançon, Besançon, France
| | - Francois Aubin
- Dermatology Department, Inserm 1098, Université de Franche Comté, CHU Besançon, Besançon, France
| | - Monica Dinulescu
- Dermatology Department, CHR Rennes, Rennes, France
- Institut Dermatologique du Grand Ouest (IDGO), Rennes, France
| | - Sebastien Visée
- Department of Pathology, Centre Hospitalier d'Angoulème, Angoulème, France
| | - Michael Herfs
- Laboratory of Experimental Pathology, GIGA-Cancer, University of Liège, Liège, Belgium
| | - Antoine Touzé
- "Biologie des Infections à Polyomavirus" Team, UMR INRAE ISP 1282, Université de Tours, Tours, France
| | - Serge Guyétant
- Department of Pathology, Université de Tours, Centre Hospitalier Universitaire de Tours, Tours, France
- "Biologie des Infections à Polyomavirus" Team, UMR INRAE ISP 1282, Université de Tours, Tours, France
| | - Mahtab Samimi
- "Biologie des Infections à Polyomavirus" Team, UMR INRAE ISP 1282, Université de Tours, Tours, France
- Departement of Dermatology, Université de Tours, Centre Hospitalier Universitaire de Tours, Tours, France
| | - Roland Houben
- Department of Dermatology, Venereology and Allergology, University Hospital Würzburg, Würzburg, Germany
| | - David Schrama
- Department of Dermatology, Venereology and Allergology, University Hospital Würzburg, Würzburg, Germany
| |
Collapse
|
3
|
Dupont A, Vergara R, Pacaud A, Dequidt L, Dutriaux C, Saunier V, Caumont C, Jullie ML, Taïeb A, Morice-Picard F, Dousset L. Giant syringocystadenocarcinoma papilliferum with conjunctival recurrence: Possible Schimmelpenning syndrome with postzygotic G13R HRAS and K601N BRAF signature. J Eur Acad Dermatol Venereol 2023; 37:e1420-e1422. [PMID: 37458522 DOI: 10.1111/jdv.19346] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/20/2023] [Accepted: 07/12/2023] [Indexed: 07/21/2023]
Affiliation(s)
- Aurore Dupont
- Department of Dermatology and Pediatric Dermatology, Hospital of Bordeaux, Bordeaux, France
- National Reference Center for Rare Skin Disorders, Hospital of Bordeaux, Bordeaux, France
| | - Rémi Vergara
- Department of Pathology, Hospital of Bordeaux, Pessac, France
| | - Alizé Pacaud
- Department of Dermatology and Pediatric Dermatology, Hospital of Bordeaux, Bordeaux, France
- National Reference Center for Rare Skin Disorders, Hospital of Bordeaux, Bordeaux, France
| | - Laure Dequidt
- Department of Dermatology and Pediatric Dermatology, Hospital of Bordeaux, Bordeaux, France
- National Reference Center for Rare Skin Disorders, Hospital of Bordeaux, Bordeaux, France
| | - Caroline Dutriaux
- Department of Dermatology and Pediatric Dermatology, Hospital of Bordeaux, Bordeaux, France
- National Reference Center for Rare Skin Disorders, Hospital of Bordeaux, Bordeaux, France
| | | | - Charline Caumont
- Laboratory of Tumor Biology and Tumor Biobank, Hospital of Bordeaux, Pessac, France
- INSERM U1312, TRIO2, University of Bordeaux, Bordeaux, France
| | | | - Alain Taïeb
- Department of Dermatology and Pediatric Dermatology, Hospital of Bordeaux, Bordeaux, France
- National Reference Center for Rare Skin Disorders, Hospital of Bordeaux, Bordeaux, France
- INSERM U1312, TRIO2, University of Bordeaux, Bordeaux, France
| | - Fanny Morice-Picard
- Department of Dermatology and Pediatric Dermatology, Hospital of Bordeaux, Bordeaux, France
- National Reference Center for Rare Skin Disorders, Hospital of Bordeaux, Bordeaux, France
- INSERM U1312, TRIO2, University of Bordeaux, Bordeaux, France
| | - Léa Dousset
- Department of Dermatology and Pediatric Dermatology, Hospital of Bordeaux, Bordeaux, France
- National Reference Center for Rare Skin Disorders, Hospital of Bordeaux, Bordeaux, France
- INSERM U1312, TRIO2, University of Bordeaux, Bordeaux, France
| |
Collapse
|
4
|
Legrand M, Pissaloux D, Tirode F, Tallet A, Collin C, Chantreau PL, Berthon P, Jullie ML, Sohier P, Calonje E, Luzar B, Moulonguet I, Goto K, Cokelaere K, Lamant L, Balme B, Deschamps L, Macagno N, Cribier B, Battistella M, de la Fouchardière A, Kervarrec T. SSTR2A is a diagnostic marker of trichogerminoma. J Eur Acad Dermatol Venereol 2023; 37:e1344-e1347. [PMID: 37421254 DOI: 10.1111/jdv.19319] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/17/2023] [Accepted: 06/27/2023] [Indexed: 07/10/2023]
Affiliation(s)
- Mélanie Legrand
- Department of Pathology, Université de Tours, Centre Hospitalier Universitaire de Tours, Tours, France
| | - Daniel Pissaloux
- Department of Biopathology, Center Léon Bérard, Lyon, France
- Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Equipe Labellisée Ligue contre le Cancer, Lyon, France
| | - Franck Tirode
- Department of Biopathology, Center Léon Bérard, Lyon, France
- Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Equipe Labellisée Ligue contre le Cancer, Lyon, France
| | - Anne Tallet
- Platform of Somatic Tumor Molecular Genetics, Université de Tours, Centre Hospitalier Universitaire de Tours, Tours, France
| | - Christine Collin
- Platform of Somatic Tumor Molecular Genetics, Université de Tours, Centre Hospitalier Universitaire de Tours, Tours, France
| | - Paul-Louis Chantreau
- Department of Pathology, Université de Tours, Centre Hospitalier Universitaire de Tours, Tours, France
| | - Patricia Berthon
- "Biologie des infections à polyomavirus" team, UMR INRA ISP 1282, Université de Tours, Tours, France
| | - Marie-Laure Jullie
- French Network of Rare Skin Cancers, CARADERM, France
- Department of Pathology, Hôpital Haut-Lévêque, CHU de Bordeaux, Pessac, France, CARADERM network
| | - Pierre Sohier
- French Network of Rare Skin Cancers, CARADERM, France
- Department of Pathology, Hôpital Cochin, AP-HP, AP-HP.Centre - Faculté de Médecine, University Paris Cité, Paris, France
| | - Eduardo Calonje
- Department of Dermatopathology, St John's Institute of Dermatology, St Thomas's Hospital, London, UK
| | - Boštjan Luzar
- Institute of Pathology, Medical Faculty University of Ljubljana, Ljubljana, Slovenia
| | - Isabelle Moulonguet
- Department of Pathology, APHP Hôpital Saint Louis, Université Paris Cité, Paris, France
| | - Keisuke Goto
- Department of Pathology, Tokyo Metropolitan Cancer and Infectious Disease Center Komagome Hospital, Tokyo, Japan
- Department of Diagnostic Pathology, Shizuoka Cancer Center Hospital, Japan
- Department of Diagnostic Pathology and Cytology, Osaka International Cancer Institute, Osaka, Japan
- Department of Dermatology, Hyogo Cancer Center, Akashi, Japan
| | | | - Laurence Lamant
- Department of Pathology, CHU Toulouse, Institut Universitaire du Cancer Toulouse Oncopole, Université Toulouse III Paul Sabatier, Toulouse, France
| | - Brigitte Balme
- Department of Pathology, Centre Hospitalier Universitaire de Lyon, Lyon, France
| | - Lydia Deschamps
- Department of Pathology, APHP Bichat Hospital, Paris, France
| | - Nicolas Macagno
- French Network of Rare Skin Cancers, CARADERM, France
- Department of Pathology, Timone University Hospital, Marseille, France
| | - Bernard Cribier
- French Network of Rare Skin Cancers, CARADERM, France
- Dermatology Clinic, Hôpitaux Universitaires & Université de Strasbourg, Hôpital Civil, Strasbourg, France
| | - Maxime Battistella
- French Network of Rare Skin Cancers, CARADERM, France
- Department of Pathology, APHP Hôpital Saint Louis, Université Paris Cité, Paris, France
| | - Arnaud de la Fouchardière
- Department of Biopathology, Center Léon Bérard, Lyon, France
- Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Equipe Labellisée Ligue contre le Cancer, Lyon, France
| | - Thibault Kervarrec
- Department of Pathology, Université de Tours, Centre Hospitalier Universitaire de Tours, Tours, France
- "Biologie des infections à polyomavirus" team, UMR INRA ISP 1282, Université de Tours, Tours, France
- French Network of Rare Skin Cancers, CARADERM, France
| |
Collapse
|
5
|
Bouquerel M, Dequidt L, Jullie ML, Beltzung F, Gibier JB, Lefevre G, Dezoteux F, Morice-Picard F, Trimouille A, Doutre MS. Wells syndrome and acquired cutis laxa: An atypical association. J Dermatol 2023; 50:e394-e395. [PMID: 37438947 DOI: 10.1111/1346-8138.16897] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/13/2022] [Revised: 06/13/2023] [Accepted: 06/29/2023] [Indexed: 07/14/2023]
Affiliation(s)
| | - Laure Dequidt
- Service de Dermatologie, CHU de Bordeaux, Bordeaux, France
| | - Marie-Laure Jullie
- Service de Pathologie, Hôpital Haut Lévêque, CHU de Bordeaux, Bordeaux, France
| | - Fanny Beltzung
- Service de Pathologie, Hôpital Haut Lévêque, CHU de Bordeaux, Bordeaux, France
| | - Jean-Baptiste Gibier
- Institut de Pathologie, Centre de Biologie Pathologie, CHU de Lille, Lille, France
| | - Guillaume Lefevre
- Centre de référence des syndromes hyperéosinophiliques, Service de Médecine interne et Immunologie Clinique, U1286 INSERM INFINITE Institute for Translationnel Research in Inflammation, Lille, France
| | - Frederic Dezoteux
- Service de Dermatologie, CHU de Lille, U1286 INSERM INFINITE Institute for Translationnel Research in Inflammation, Lille, France
| | - Fanny Morice-Picard
- Service de Dermatologie, CHU de Bordeaux, Bordeaux, France
- Service de Dermatologie, Centre de référence des maladies rares de la peau, CHU de Bordeaux, Bordeaux, France
| | - Aurelien Trimouille
- Service de Dermatologie, Centre de référence des maladies rares de la peau, CHU de Bordeaux, Bordeaux, France
- Service de Pathologie Hôpital Pellegrin, CHU de Bordeaux, Bordeaux, France
| | | |
Collapse
|
6
|
Kervarrec T, Tallet A, Macagno N, de la Fouchardière A, Pissaloux D, Tirode F, Bravo IG, Nicolas A, Baulande S, Sohier P, Balme B, Osio A, Jullie ML, Moulonguet I, Bonsang B, Tournier E, Herfs M, Frouin E, Zidan A, Calonje E, Berthon P, Touzé A, Seris A, Mortier L, Jouary T, Cribier B, Battistella M. Sweat Gland Tumors Arising on Acral Sites: A Molecular Survey. Am J Surg Pathol 2023; 47:1096-1107. [PMID: 37505808 DOI: 10.1097/pas.0000000000002098] [Citation(s) in RCA: 3] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 07/29/2023]
Abstract
Recurrent oncogenic drivers have been identified in a variety of sweat gland tumors. Recently, integration of human papillomavirus type 42 (HPV42) has been reported in digital papillary adenocarcinoma (DPA). The main objectives of the present study were (i) to provide an overview of the prevalence of previously identified oncogenic drivers in acral sweat gland tumors and (ii) to genetically characterize tumors in which no recurrent genetic alteration has been identified yet. Cases of acral sweat gland tumors were identified from the database of the French network CARADERM. After histologic review, the presence of previously identified genetic alterations was investigated in the entire cohort (n=79) using a combination of immunohistochemistry and targeted DNA and RNA sequencing. Tumor entities with no recurrent genetic alterations were submitted to whole-transcriptome sequencing. CRTC1::MAML2 fusion was identified in cases of hidradenoma and hidradenocarcinoma (n=9/12 and n=9/12). A p.V600E mutation of BRAF was observed in all cases of tubular adenoma (n=4). YAP1:MAML2 and YAP1::NUTM1 fusions were observed in poroid tumors (n=15/25). ETV6::NTRK3 and TRPS1::PLAG1 fusion transcripts were identified in secretory carcinoma (n=1/1) and cutaneous mixed tumors (n=3/4), respectively. The HPV42 genome was detected in most cases of DPA (n=10/11) and in 1 adnexal adenocarcinoma not otherwise specified. Finally, whole-transcriptome analysis revealed BRD3::NUTM1 or NSD3::NUTM1 fusions in 2 cases of NUT adnexal carcinoma and NCOA4::RET and CCDC6::RET fusion transcripts in 2 cystadenoma/hidrocystoma-like tumors. Our study confirms distinctive cytogenetic abnormalities in a wide number of acral adnexal neoplasms and supports the use of molecular analysis as a valuable aid in the diagnosis of these rare and often difficult to diagnose group of neoplasms.
Collapse
Affiliation(s)
- Thibault Kervarrec
- CARADERM, French Network of Rare Cutaneous Cancer
- Department of Pathology, University Hospital Center of Tours
- "Biologie des infections polyomavirus" Team, UMR INRA ISP1282, University of Tours
| | - Anne Tallet
- Platform of Solid Tumor Molecular Genetics, University Hospital Center of Tours, Tours
| | - Nicolas Macagno
- CARADERM, French Network of Rare Cutaneous Cancer
- Department of Pathology, APHM, Timone University Hospital
- Aix Marseille University, INSERM, MMG, UMR1251, Marmara Institute, Marseille
| | - Arnaud de la Fouchardière
- CARADERM, French Network of Rare Cutaneous Cancer
- Department of Biopathology, Center Léon Bérard
- University of Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Equipe Labellisée Ligue contre le Cancer
| | - Daniel Pissaloux
- Department of Biopathology, Center Léon Bérard
- University of Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Equipe Labellisée Ligue contre le Cancer
| | - Franck Tirode
- University of Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Equipe Labellisée Ligue contre le Cancer
| | - Ignacio G Bravo
- French National Center for Scientific Research (CNRS), Laboratory MIVEGEC (CNRS IRD Univ Montpellier), Montpellier
| | - Alain Nicolas
- Institut Curie, PSL Research University, CNRS UMR3244
| | | | - Pierre Sohier
- CARADERM, French Network of Rare Cutaneous Cancer
- Faculté de Médecine Paris Centre Santé, University of Paris
- Department of Pathology, Cochin Hospital, AP-HP, AP-HP Centre-Université de Paris
| | - Brigitte Balme
- CARADERM, French Network of Rare Cutaneous Cancer
- Department of Pathology, University Hospital Center of Lyon-Sud, Hospices Civils de Lyon, Lyon
| | - Amélie Osio
- CARADERM, French Network of Rare Cutaneous Cancer
- National Center of Dermatopathology, Paris-la Roquette, Ivry
| | - Marie-Laure Jullie
- CARADERM, French Network of Rare Cutaneous Cancer
- Department of Pathology, University Hospital Center of Bordeaux, Pessac
| | | | - Benjamin Bonsang
- CARADERM, French Network of Rare Cutaneous Cancer
- Department of Pathology, Hôpital Ambroise Pare, AP-HP
| | - Emilie Tournier
- CARADERM, French Network of Rare Cutaneous Cancer
- Department of Pathology, CHU Toulouse, Institut Universitaire du Cancer de Toulouse Oncopole
- Université Toulouse III Paul Sabatier, Toulouse
| | - Michael Herfs
- Laboratory of Experimental Pathology, GIGA-Cancer, University of Liège, Liège, Belgium
| | - Eric Frouin
- Department of Pathology, University Hospital Center of Poitiers, LITEC, UR 15560, University of Poitiers, Poitiers
| | - Anoud Zidan
- Dermatopathology Laboratory, St John's Institute of Dermatology, St Thomas' Hospital, London, UK
| | - Eduardo Calonje
- Dermatopathology Laboratory, St John's Institute of Dermatology, St Thomas' Hospital, London, UK
| | - Patricia Berthon
- "Biologie des infections polyomavirus" Team, UMR INRA ISP1282, University of Tours
| | - Antoine Touzé
- "Biologie des infections polyomavirus" Team, UMR INRA ISP1282, University of Tours
| | - Alice Seris
- CARADERM, French Network of Rare Cutaneous Cancer
- Department of Dermatology, Hospital Center of Pau, Pau
| | - Laurent Mortier
- CARADERM, French Network of Rare Cutaneous Cancer
- Department of Dermatology, University Hospital Center of Lille, Lille
| | - Thomas Jouary
- CARADERM, French Network of Rare Cutaneous Cancer
- Department of Dermatology, Hospital Center of Pau, Pau
| | - Bernard Cribier
- CARADERM, French Network of Rare Cutaneous Cancer
- Clinique Dermatologique, Hôpitaux Universitaires & Université de Strasbourg, Hôpital Civil, Strasbourg, France
| | - Maxime Battistella
- CARADERM, French Network of Rare Cutaneous Cancer
- Department of Pathology, Hopital Saint Louis, AP-HP Universite ́ Paris 7, Paris
| |
Collapse
|
7
|
Letertre O, Jullie ML, Reboul MP, Leclerc-Mercier S, Charbit F, Boralevi F, Labrèze C, Hadj-Rabia S, Morice-Picard F. Mosaic GJB2 mutation A88V leading to diffuse neonatal hyperkeratosis and porokeratotic hamartoma. J Eur Acad Dermatol Venereol 2023; 37:e801-e803. [PMID: 36734293 DOI: 10.1111/jdv.18935] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/28/2022] [Accepted: 02/01/2023] [Indexed: 02/04/2023]
Affiliation(s)
- O Letertre
- Department of Dermatology and Pediatric Dermatology, National Reference Centre for Rare Disorders, Hôpital des Enfants Pellegrin, European Network Skin Diseases, Centre Hospitalier Universitaire du Bordeaux, Bordeaux, France
| | - M L Jullie
- Department of Pathology, CHU de Bordeaux, Pessac, France
| | - M P Reboul
- Department of Medical Genetics, CHU de Bordeaux, Bordeaux, France
| | - S Leclerc-Mercier
- Department of Pathology and Reference Center for Genodermatoses (MAGEC Center), Necker-Enfants Malades Hospital, Paris Centre University, Paris, France
| | - F Charbit
- Department of Genetics and Reference Center for Genodermatoses (MAGEC Center), Necker-Enfants Malades Hospital, Paris Centre University, Paris, France
| | - F Boralevi
- Department of Dermatology and Pediatric Dermatology, National Reference Centre for Rare Disorders, Hôpital des Enfants Pellegrin, European Network Skin Diseases, Centre Hospitalier Universitaire du Bordeaux, Bordeaux, France
| | - C Labrèze
- Department of Dermatology and Pediatric Dermatology, National Reference Centre for Rare Disorders, Hôpital des Enfants Pellegrin, European Network Skin Diseases, Centre Hospitalier Universitaire du Bordeaux, Bordeaux, France
| | - S Hadj-Rabia
- Department of Dermatology and Reference Center for Genodermatoses (MAGEC Center), Necker-Enfants Malades Hospital, Paris Centre University, Paris, France
| | - F Morice-Picard
- Department of Dermatology and Pediatric Dermatology, National Reference Centre for Rare Disorders, Hôpital des Enfants Pellegrin, European Network Skin Diseases, Centre Hospitalier Universitaire du Bordeaux, Bordeaux, France
| |
Collapse
|
8
|
Kervarrec T, Frouin E, Collin C, Tallet A, Tallegas M, Pissaloux D, Tirode F, Guyétant S, Samimi M, Gaboriaud P, Touzé A, Schrama D, Houben R, Tabareau-Delalande F, Neuhart A, de la Fouchardière A, Osio A, Cavelier-Balloy B, Laurent-Roussel S, Sohier P, Cyprien T, Balme B, Belzung F, Jullie ML, Cribier B, Battistella M, Macagno N. Distinct regulations driving YAP1 expression loss in poroma, porocarcinoma and RB1-deficient skin carcinoma. Histopathology 2023; 82:885-898. [PMID: 36720791 DOI: 10.1111/his.14874] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/21/2022] [Revised: 12/22/2022] [Accepted: 01/15/2023] [Indexed: 02/02/2023]
Abstract
AIMS Recently, YAP1 fusion genes have been demonstrated in eccrine poroma and porocarcinoma, and the diagnostic use of YAP1 immunohistochemistry has been highlighted in this setting. In other organs, loss of YAP1 expression can reflect YAP1 rearrangement or transcriptional repression, notably through RB1 inactivation. In this context, our objective was to re-evaluate the performance of YAP1 immunohistochemistry for the diagnosis of poroma and porocarcinoma. METHODS AND RESULTS The expression of the C-terminal part of the YAP1 protein was evaluated by immunohistochemistry in 543 cutaneous epithelial tumours, including 27 poromas, 14 porocarcinomas and 502 other cutaneous tumours. Tumours that showed a lack of expression of YAP1 were further investigated for Rb by immunohistochemistry and for fusion transcripts by real-time PCR (YAP1::MAML2 and YAP1::NUTM1). The absence of YAP1 expression was observed in 24 cases of poroma (89%), 10 porocarcinoma (72%), 162 Merkel cell carcinoma (98%), 14 squamous cell carcinoma (SCC) (15%), one trichoblastoma and one sebaceoma. Fusions of YAP1 were detected in only 16 cases of poroma (n = 66%), 10 porocarcinoma (71%) all lacking YAP1 expression, and in one sebaceoma. The loss of Rb expression was detected in all cases except one of YAP1-deficient SCC (n = 14), such tumours showing significant morphological overlap with porocarcinoma. In-vitro experiments in HaCat cells showed that RB1 knockdown resulted in repression of YAP1 protein expression. CONCLUSION In addition to gene fusion, we report that transcriptional repression of YAP1 can be observed in skin tumours with RB1 inactivation, including MCC and a subset of SCC.
Collapse
Affiliation(s)
- Thibault Kervarrec
- CARADERM, French Network of Rare Cutaneous Cancer, Lille, France.,Department of Pathology, University Hospital of Tours, Tours, France.,'Biologie des Infections à Polyomavirus' Team, UMR1282 INRAE, University of Tours, Tours, France
| | - Eric Frouin
- CARADERM, French Network of Rare Cutaneous Cancer, Lille, France.,Department of Pathology, University Hospital of Poitiers, University of Poitiers, LITEC, Poitiers, France
| | - Christine Collin
- Platform of Solid Tumor Molecular Genetics, University Hospital Center of Tours, Tours, France
| | - Anne Tallet
- Platform of Solid Tumor Molecular Genetics, University Hospital Center of Tours, Tours, France
| | - Matthias Tallegas
- Platform of Solid Tumor Molecular Genetics, University Hospital Center of Tours, Tours, France
| | - Daniel Pissaloux
- Department of Biopathology, Center Léon Bérard, Lyon, France.,University of Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Equipe Labellisée Ligue contre le Cancer, Lyon, France
| | - Franck Tirode
- Department of Biopathology, Center Léon Bérard, Lyon, France.,University of Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Equipe Labellisée Ligue contre le Cancer, Lyon, France
| | - Serge Guyétant
- Department of Pathology, University Hospital of Tours, Tours, France.,'Biologie des Infections à Polyomavirus' Team, UMR1282 INRAE, University of Tours, Tours, France.,Department of Pathology, University Hospital of Poitiers, University of Poitiers, LITEC, Poitiers, France
| | - Mahtab Samimi
- Department of Dermatology, University Hospital Center of Tours, Tours, France
| | - Pauline Gaboriaud
- 'Biologie des Infections à Polyomavirus' Team, UMR1282 INRAE, University of Tours, Tours, France
| | - Antoine Touzé
- 'Biologie des Infections à Polyomavirus' Team, UMR1282 INRAE, University of Tours, Tours, France
| | - David Schrama
- Department of Dermatology, Venereology and Allergology, University Hospital Würzburg, Würzburg, Germany
| | - Roland Houben
- Department of Dermatology, Venereology and Allergology, University Hospital Würzburg, Würzburg, Germany
| | | | - Anne Neuhart
- Department of Biopathology, Center Léon Bérard, Lyon, France
| | - Arnaud de la Fouchardière
- CARADERM, French Network of Rare Cutaneous Cancer, Lille, France.,Department of Biopathology, Center Léon Bérard, Lyon, France.,University of Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Equipe Labellisée Ligue contre le Cancer, Lyon, France
| | - Amélie Osio
- CARADERM, French Network of Rare Cutaneous Cancer, Lille, France.,Department of Pathology, Hospital Saint-Louis, AP-HP, Université Paris Cité, INSERM U976, Paris, France.,Centre National de Dermatopathologie, Paris-la Roquette, Ivry, France
| | | | - Sara Laurent-Roussel
- Centre National de Dermatopathologie, Paris-la Roquette, Ivry, France.,Cabinet Mathurin Moreau, Paris, France
| | - Pierre Sohier
- CARADERM, French Network of Rare Cutaneous Cancer, Lille, France.,Department of Pathology, Hôpital Cochin, AP-HP, AP-HP.Centre - Université Paris Cité, Paris, France.,Faculté de Médecine, University Paris Cité, Paris, France
| | - Tilmant Cyprien
- CARADERM, French Network of Rare Cutaneous Cancer, Lille, France.,Department of Pathology, Groupement des Hopitaux de l'institut catholique de Lille, Lille, France
| | - Brigitte Balme
- CARADERM, French Network of Rare Cutaneous Cancer, Lille, France.,Department of Pathology, University Hospital of Lyon Sud, Lyon, France
| | - Fanny Belzung
- Department of Pathology, University Hospital of Bordeaux, Bordeaux, France
| | - Marie-Laure Jullie
- CARADERM, French Network of Rare Cutaneous Cancer, Lille, France.,Department of Pathology, University Hospital of Bordeaux, Bordeaux, France
| | - Bernard Cribier
- CARADERM, French Network of Rare Cutaneous Cancer, Lille, France.,Clinique Dermatologique, Hôpitaux Universitaires and Université de Strasbourg, Hôpital Civil, Strasbourg, France
| | - Maxime Battistella
- CARADERM, French Network of Rare Cutaneous Cancer, Lille, France.,Department of Pathology, Hospital Saint-Louis, AP-HP, Université Paris Cité, INSERM U976, Paris, France
| | - Nicolas Macagno
- CARADERM, French Network of Rare Cutaneous Cancer, Lille, France.,Department of Pathology, APHM, Timone University Hospital, Marseille, France.,Aix-Marseille University, INSERM U1251, MMG, Marseille, France
| |
Collapse
|
9
|
Hazard M, Hans P, Jullie ML, Doutre MS. Acquired Elastotic Hemangioma With Multiple Lesions: A Case Report. Am J Dermatopathol 2022; 44:437-438. [PMID: 35170476 DOI: 10.1097/dad.0000000000002158] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Affiliation(s)
- Madeleine Hazard
- Department of Dermatology, Hôpital Saint André, CHU de Bordeaux, Bordeaux, France
| | | | - Marie-Laure Jullie
- Department of Pathology, Hôpital Haut-Levêque, CHU de Bordeaux, Bordeaux, France
| | - Marie-Sylvie Doutre
- Department of Dermatology, Hôpital Saint André, CHU de Bordeaux, Bordeaux, France
| |
Collapse
|
10
|
Battistella M, Balme B, Jullie ML, Zimmermann U, Carlotti A, Crinquette M, Frouin E, Macagno N, Ortonne N, Lamant L, de la Fouchardiere A, Aubriot-lorton MH, Durand L, Josselin N, Franck F, Chatelain D, Lemasson G, Algros MP, Durlach A, Machet MC, Courville P, Osio A, Seris A, Mortier L, Jouary T, Cribier B. Impact of expert pathology review in skin adnexal carcinoma diagnosis: Analysis of 2573 patients from the French CARADERM network. Eur J Cancer 2022; 163:211-221. [DOI: 10.1016/j.ejca.2021.11.027] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/23/2021] [Revised: 10/19/2021] [Accepted: 11/26/2021] [Indexed: 11/30/2022]
|
11
|
Kervarrec T, Berthon P, Thanguturi S, Guyétant S, Macagno N, Jullie ML. Reevaluation of GLI1 Expression in Skin Tumors. Am J Dermatopathol 2021; 43:759-761. [PMID: 33577176 DOI: 10.1097/dad.0000000000001917] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
Affiliation(s)
- Thibault Kervarrec
- Department of Pathology, Université de Tours, Centre Hospitalier Universitaire de Tours, Tours, France
- "Biologie des Infections à Polyomavirus" Team, UMR INRA ISP 1282, Université de Tours, Tours, France
- CARADERM, French Network of Rare Cutaneous Cancer
| | - Patricia Berthon
- "Biologie des Infections à Polyomavirus" Team, UMR INRA ISP 1282, Université de Tours, Tours, France
| | - Soumanth Thanguturi
- Department of Pathology, Université de Tours, Centre Hospitalier Universitaire de Tours, Tours, France
| | - Serge Guyétant
- Department of Pathology, Université de Tours, Centre Hospitalier Universitaire de Tours, Tours, France
- "Biologie des Infections à Polyomavirus" Team, UMR INRA ISP 1282, Université de Tours, Tours, France
| | - Nicolas Macagno
- CARADERM, French Network of Rare Cutaneous Cancer
- Department of Pathology, Timone University Hospital, Marseille, France
| | - Marie-Laure Jullie
- CARADERM, French Network of Rare Cutaneous Cancer
- Department of Pathology, Hôpital Haut-Lévêque, CHU de Bordeaux, Pessac, France
| |
Collapse
|
12
|
Kervarrec T, Appenzeller S, Samimi M, Sarma B, Sarosi EM, Berthon P, Le Corre Y, Hainaut-Wierzbicka E, Blom A, Benethon N, Bens G, Nardin C, Aubin F, Dinulescu M, Jullie ML, Pekár-Lukacs Á, Calonje E, Thanguturi S, Tallet A, Wobser M, Touzé A, Guyétant S, Houben R, Schrama D. Merkel Cell Polyomavirus‒Negative Merkel Cell Carcinoma Originating from In Situ Squamous Cell Carcinoma: A Keratinocytic Tumor with Neuroendocrine Differentiation. J Invest Dermatol 2021; 142:516-527. [PMID: 34480892 DOI: 10.1016/j.jid.2021.07.175] [Citation(s) in RCA: 16] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/14/2021] [Revised: 06/24/2021] [Accepted: 07/09/2021] [Indexed: 12/21/2022]
Abstract
Although virus-negative Merkel cell carcinoma (MCC) is characterized by a high frequency of UV-induced mutations, the expression of two viral oncoproteins is regarded as a key mechanism driving Merkel cell polyomavirus‒positive MCC. The cells in which these molecular events initiate MCC oncogenesis have yet not been identified for both MCC subsets. A considerable proportion of virus-negative MCC is found in association with squamous cell carcinoma (SCC), suggesting (i) coincidental collision, (ii) one providing a niche for the other, or (iii) one evolving from the other. Whole-exome sequencing of four combined tumors consisting of SCC in situ and Merkel cell polyomavirus‒negative MCC showed many mutations shared between SCC and MCC in all cases, indicating a common ancestry and thereby a keratinocytic origin of these MCCs. Moreover, analyses of the combined cases as well as of pure SCC and MCC suggest that RB1 inactivation in SCC facilitates MCC development and that epigenetic changes may contribute to the SCC/MCC transition.
Collapse
Affiliation(s)
- Thibault Kervarrec
- Department of Pathology, University Hospital Center of Tours, University of Tours, Tours, France; Biologie des infections à polyomavirus team, UMR INRAE ISP 1282, University of Tours, Tours, France; Department of Dermatology, Venereology and Allergology, University Hospital Würzburg, Würzburg, Germany.
| | - Silke Appenzeller
- Core Unit Bioinformatics, Comprehensive Cancer Center Mainfranken, University Hospital Würzburg, Würzburg, Germany
| | - Mahtab Samimi
- Biologie des infections à polyomavirus team, UMR INRAE ISP 1282, University of Tours, Tours, France; Department of Dermatology, University Hospital Center of Tours, University of Tours, Tours, France
| | - Bhavishya Sarma
- Department of Dermatology, Venereology and Allergology, University Hospital Würzburg, Würzburg, Germany
| | - Eva-Maria Sarosi
- Department of Dermatology, Venereology and Allergology, University Hospital Würzburg, Würzburg, Germany
| | - Patricia Berthon
- Biologie des infections à polyomavirus team, UMR INRAE ISP 1282, University of Tours, Tours, France
| | - Yannick Le Corre
- Dermatology Department, LUNAM University, University Hospital Center of Angers, Angers, France
| | - Ewa Hainaut-Wierzbicka
- Dermatology Department, University Hospital Center of Poitiers, University of Poitiers, Poitiers, France
| | - Astrid Blom
- Department of General and Oncologic Dermatology, Ambroise-Paré hospital, APHP, Boulogne-Billancourt, France
| | | | - Guido Bens
- Dermatology Department, Hospital Center of Orléans, Orléans, France
| | - Charline Nardin
- Dermatology Department, University Hospital Center of Besançon, University of Franche Comté, Besançon, France
| | - Francois Aubin
- Dermatology Department, University Hospital Center of Besançon, University of Franche Comté, Besançon, France
| | - Monica Dinulescu
- Dermatology Department, University Hospital Center of Rennes, Rennes, France; "Institut Dermatologie du Grand Ouest" (IDGO), Nantes, France
| | - Marie-Laure Jullie
- Department of Pathology, Hôpital Haut-Lévêque, University Hospital Center of Bordeaux, CARADERM network, Pessac, France
| | - Ágnes Pekár-Lukacs
- Department of Oncology and Pathology, Lund University, Lund, Sweden; Department of Dermatopathology, St John's Institute of Dermatology, St Thomas's Hospital, London, United Kingdom
| | - Eduardo Calonje
- Department of Dermatopathology, St John's Institute of Dermatology, St Thomas's Hospital, London, United Kingdom
| | - Soumanth Thanguturi
- Department of Pathology, University Hospital Center of Tours, University of Tours, Tours, France
| | - Anne Tallet
- Platform of Somatic Tumor Molecular Genetics, University Hospital Center of Tours, Université de Tours, Tours, France
| | - Marion Wobser
- Department of Dermatology, Venereology and Allergology, University Hospital Würzburg, Würzburg, Germany
| | - Antoine Touzé
- Biologie des infections à polyomavirus team, UMR INRAE ISP 1282, University of Tours, Tours, France
| | - Serge Guyétant
- Department of Pathology, University Hospital Center of Tours, University of Tours, Tours, France; Biologie des infections à polyomavirus team, UMR INRAE ISP 1282, University of Tours, Tours, France
| | - Roland Houben
- Department of Dermatology, Venereology and Allergology, University Hospital Würzburg, Würzburg, Germany
| | - David Schrama
- Department of Dermatology, Venereology and Allergology, University Hospital Würzburg, Würzburg, Germany
| |
Collapse
|
13
|
Letertre O, Anii V, Jullie ML, Milpied B, Seneschal J, Darrigade AS. Linear immunoglobulin A bullous dermatosis associated with disseminated tuberculosis. Int J Dermatol 2021; 60:e361-e362. [PMID: 33742695 DOI: 10.1111/ijd.15526] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/28/2020] [Revised: 02/12/2021] [Accepted: 02/26/2021] [Indexed: 11/29/2022]
Affiliation(s)
- Oriane Letertre
- Department of Dermatology, Hôpital Saint André, CHU de Bordeaux, France
| | - Veronica Anii
- Department of Internal Medicine, CH d'Arcachon, France
| | - Marie-Laure Jullie
- Department of Pathology, Hôpital du Haut Lévêque, CHU de Bordeaux, France
| | - Brigitte Milpied
- Department of Dermatology, Hôpital Saint André, CHU de Bordeaux, France
| | - Julien Seneschal
- Department of Dermatology, Hôpital Saint André, CHU de Bordeaux, France
| | | |
Collapse
|
14
|
Fauconneau A, Sokolowsky N, Camus M, Darrigade AS, Guillet S, Jullie ML, Beylot-Barry M, Doutre MS. Acquired cutis laxa associated with neutrophilic urticarial dermatosis. Int J Dermatol 2020; 60:771-772. [PMID: 33226126 DOI: 10.1111/ijd.15314] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/04/2020] [Revised: 10/18/2020] [Accepted: 10/22/2020] [Indexed: 11/30/2022]
Affiliation(s)
| | - Nina Sokolowsky
- Department of Dermatology, Hôpital Saint André, Bordeaux, France
| | | | | | | | | | | | | |
Collapse
|
15
|
Stoupa A, Al Hage Chehade G, Kariyawasam D, Tohier C, Bole-Feysot C, Nitschke P, Thibault H, Jullie ML, Polak M, Carré A. First case of fetal goitrous hypothyroidism due to SLC5A5/NIS mutations. Eur J Endocrinol 2020; 183:K1-K5. [PMID: 32805706 DOI: 10.1530/eje-20-0255] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/20/2020] [Accepted: 08/17/2020] [Indexed: 11/08/2022]
Abstract
BACKGROUND Among patients with congenital hypothyroidism, 35% have dyshormonogenesis (DH) with thyroid gland in situ with or without goiter. The majority of DH cases are due to mutations in genes involved in thyroid hormone production as TG, TPO, SLC5A5/NIS, SLC26A4/PDS, IYD/DEHAL1, DUOX2, and DUOXA2, and are usually inherited on an autosomal recessive basis. Most previously reported cases of fetal hypothyroidism and goiter were related to TG or TPO mutations and recently DUOXA2. PATIENT In a male patient with antenatal goiter treated with intraamniotic levothyroxine injections, whose long-term follow-up is described in detail, two novel NIS mutations were detected. Mutations of NIS were located in exon 1 (c.52G>A, p.G18R) and exon 13 (c.1546C>T, p.R516X), each mutation was inherited from parents, who are healthy carriers. The p.G18R mutation affecting the first transmembrane domain of the protein can be responsible for deficient iodide uptake. However, the second is a nonsense mutation leading probably to mRNA degradation. In addition, the patient has undergone a thyroidectomy and we have studied the thyroid tissue. The thyroid histology showed heterogeneity with large follicles, epithelial hyperplasia and many areas of fibrosis. Immunohistochemistry with NIS specific antibody showed NIS staining at the basolateral plasma membrane of the thyrocytes. CONCLUSIONS We report the first case of fetal goitrous hypothyroidism due to two novel NIS mutations with access to thyroid tissue of the patient, specific histology studies and long-term follow-up. This case expands our knowledge and provides further insights on molecular causes of fetal goiter in humans.
Collapse
Affiliation(s)
- Athanasia Stoupa
- INSERM U1016, Cochin Institute, Faculté de Médecine, Université Paris Descartes, Sorbonne Paris Cité, Paris, France
- IMAGINE Institute affiliate, Paris, France
- Pediatric Endocrinology, Gynecology and Diabetology Unit, Hôpital Universitaire Necker-Enfants Malades, AP-HP, Paris, France
| | - Ghada Al Hage Chehade
- Pediatric Endocrinology, Gynecology and Diabetology Unit, Hôpital Universitaire Necker-Enfants Malades, AP-HP, Paris, France
| | - Dulanjalee Kariyawasam
- Pediatric Endocrinology, Gynecology and Diabetology Unit, Hôpital Universitaire Necker-Enfants Malades, AP-HP, Paris, France
| | - Celine Tohier
- INSERM U1016, Cochin Institute, Faculté de Médecine, Université Paris Descartes, Sorbonne Paris Cité, Paris, France
| | - Christine Bole-Feysot
- Genomics Platform, INSERM UMR 1163, Imagine Institute, Paris Descartes Sorbonne Paris Cite University, Paris, France
| | - Patrick Nitschke
- Bioinformatics Platform, IMAGINE Institute, Paris Descartes University, Paris, France
| | | | | | - Michel Polak
- INSERM U1016, Cochin Institute, Faculté de Médecine, Université Paris Descartes, Sorbonne Paris Cité, Paris, France
- IMAGINE Institute affiliate, Paris, France
- Pediatric Endocrinology, Gynecology and Diabetology Unit, Hôpital Universitaire Necker-Enfants Malades, AP-HP, Paris, France
- Centre de Référence des Maladies Endocriniennes Rares de la Croissance et du Développement, Necker-Enfants Malades University Hospital, Paris, France
- Centre régional de dépistage néonatal (CRDN) Ile de France, Paris, France
| | - Aurore Carré
- INSERM U1016, Cochin Institute, Faculté de Médecine, Université Paris Descartes, Sorbonne Paris Cité, Paris, France
- IMAGINE Institute affiliate, Paris, France
| |
Collapse
|
16
|
Braun V, Prey S, Gurioli C, Boralevi F, Taieb A, Grenier N, Loot M, Jullie ML, Léauté-Labrèze C. Congenital haemangiomas: a single-centre retrospective review. BMJ Paediatr Open 2020; 4:e000816. [PMID: 33324762 PMCID: PMC7722829 DOI: 10.1136/bmjpo-2020-000816] [Citation(s) in RCA: 14] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/23/2020] [Revised: 09/29/2020] [Accepted: 10/20/2020] [Indexed: 12/17/2022] Open
Abstract
OBJECTIVE Congenital haemangiomas (CHs) are rare, benign vascular tumours that are fully developed at birth. Three subtypes of CHs have been described based on clinical behaviour: rapidly involuting CHs (RICHs), non-involuting CHs (NICHs) and partially involuting CHs (PICHs). We explore in our study clinical, evolutionary and paraclinical characteristics of the three CH subtypes. DESIGN Children with CH attending our department of paediatric dermatology at Bordeaux University Hospital over a 13-year period were retrospectively included. Epidemiological, clinical and evolutionary data, photographs and imaging results were reviewed. All available tissue samples were histologically examined. RESULTS We included 57 patients: 22 with RICH, 22 with NICH and 13 with PICH. Males predominated (ratio 1.7); the most common CH location was on the limbs. RICH, NICH and PICH exhibited overlapping characteristics; all were single telangiectatic lesions with pale peripheral halos. At birth, NICHs were flat but RICHs and PICHs bulky. The median age at complete RICH involution was 12 months. One-third of CHs that appeared RICH-like at birth underwent incomplete involution to become PICHs. Heart failure and thrombocytopenia were rare complications. PICHs were frequently ulcerated. Pain was common for NICH and PICH. The imaging and histological data of the three CH subtypes were rather similar. CONCLUSIONS We describe the characteristics and evolution of the three CH subtypes using a case series. Certain overlapping features were apparent, reinforcing the hypothesis that RICH, NICH and PICH lie on the same pathological spectrum.
Collapse
Affiliation(s)
| | - Sorilla Prey
- Dermatology, CHU de Bordeaux, Bordeaux, France.,INSERM U1035, Université de Bordeaux, Talence, France
| | - Carlotta Gurioli
- Department of Specialized, Experimental and Diagnostic Medicine, Dermatology, University of Bologna, University of Bologna, Bologna, Emilia-Romagna, Italy
| | - Franck Boralevi
- Dermatology, CHU de Bordeaux, Bordeaux, France.,INSERM U1035, Université de Bordeaux, Talence, France
| | - Alain Taieb
- Dermatology, CHU de Bordeaux, Bordeaux, France.,INSERM U1035, Université de Bordeaux, Talence, France
| | - Nicolas Grenier
- Department of Radiology, CHU de Bordeaux, Bordeaux, Aquitaine, France
| | - Maya Loot
- Paediatric Surgery Department, CHU de Bordeaux, Bordeaux, Aquitaine, France
| | | | - Christine Léauté-Labrèze
- Dermatology, CHU de Bordeaux, Bordeaux, France.,INSERM U1035, Université de Bordeaux, Talence, France
| |
Collapse
|
17
|
Legrand A, Jullie ML, Ly S, Beylot-Barry M, Viallard JF, Calonje J, Bureau-Lenoir C, Doutre MS. Extrafacial necrobiotic xanthogranuloma and monoclonal gammopathy: two cases. Int J Dermatol 2019; 58:e112-e114. [PMID: 30883695 DOI: 10.1111/ijd.14416] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/17/2018] [Revised: 01/23/2019] [Accepted: 02/05/2019] [Indexed: 11/30/2022]
Affiliation(s)
- Adeline Legrand
- Dermatology Department, University Hospital of Bordeaux, Bordeaux, France
| | | | - Sandra Ly
- Dermatology Department, University Hospital of Bordeaux, Bordeaux, France
| | - Marie Beylot-Barry
- Dermatology Department, University Hospital of Bordeaux, Bordeaux, France
| | | | - Jaime Calonje
- Dermatopathology Laboratory, St John's Institute of Dermatology, St Thomas' Hospital, London, UK
| | | | | |
Collapse
|
18
|
Kasraian Z, Trompezinski S, Cario-André M, Morice-Picard F, Ged C, Jullie ML, Taieb A, Rezvani HR. Pigmentation abnormalities in nucleotide excision repair disorders: Evidence and hypotheses. Pigment Cell Melanoma Res 2018; 32:25-40. [PMID: 29938913 DOI: 10.1111/pcmr.12720] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/02/2018] [Revised: 05/11/2018] [Accepted: 06/11/2018] [Indexed: 12/12/2022]
Abstract
Skin pigmentation abnormalities are manifested in several disorders associated with deficient DNA repair mechanisms such as nucleotide excision repair (NER) and double-strand break (DSB) diseases, a topic that has not received much attention up to now. Hereditary disorders associated with defective DNA repair are valuable models for understanding mechanisms that lead to hypo- and hyperpigmentation. Owing to the UV-associated nature of abnormal pigmentary manifestations, the outcome of the activated DNA damage response (DDR) network could be the effector signal for alterations in pigmentation, ultimately manifesting as pigmentary abnormalities in repair-deficient disorders. In this review, the role of the DDR network in the manifestation of pigmentary abnormalities in NER and DSB disorders is discussed with a special emphasis on NER disorders.
Collapse
Affiliation(s)
- Zeinab Kasraian
- NAOS, Aix en Provence, France.,Univ. Bordeaux, Inserm, BMGIC, UMR 1035, Bordeaux, France
| | | | - Muriel Cario-André
- Univ. Bordeaux, Inserm, BMGIC, UMR 1035, Bordeaux, France.,Centre de Référence pour les Maladies Rares de la Peau, CHU de Bordeaux, Bordeaux, France
| | - Fanny Morice-Picard
- Centre de Référence pour les Maladies Rares de la Peau, CHU de Bordeaux, Bordeaux, France.,Service de Dermatologie Adulte et Pédiatrique, CHU de Bordeaux, Bordeaux, France
| | - Cécile Ged
- Univ. Bordeaux, Inserm, BMGIC, UMR 1035, Bordeaux, France.,Centre de Référence pour les Maladies Rares de la Peau, CHU de Bordeaux, Bordeaux, France
| | | | - Alain Taieb
- Univ. Bordeaux, Inserm, BMGIC, UMR 1035, Bordeaux, France.,Centre de Référence pour les Maladies Rares de la Peau, CHU de Bordeaux, Bordeaux, France.,Service de Dermatologie Adulte et Pédiatrique, CHU de Bordeaux, Bordeaux, France
| | - Hamid Reza Rezvani
- Univ. Bordeaux, Inserm, BMGIC, UMR 1035, Bordeaux, France.,Centre de Référence pour les Maladies Rares de la Peau, CHU de Bordeaux, Bordeaux, France
| |
Collapse
|
19
|
Dupuis F, Lamant L, Gerard E, Torossian N, Chaltiel L, Filleron T, Beylot-Barry M, Dutriaux C, Prey S, Gros A, Jullie ML, Meyer N, Vergier B. Clinical, histological and molecular predictors of metastatic melanoma responses to anti-PD-1 immunotherapy. Br J Cancer 2018; 119:193-199. [PMID: 29973670 PMCID: PMC6048096 DOI: 10.1038/s41416-018-0168-9] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/14/2018] [Revised: 04/17/2018] [Accepted: 06/08/2018] [Indexed: 01/08/2023] Open
Abstract
BACKGROUND Prescribing anti-programmed death-1 (PD-1) immunotherapy for advanced melanoma is currently not restricted by any biomarker assessment. Determination of programmed death-ligand-1 (PD-L1)-expression status is technically challenging and is not mandatory, because negative tumours also achieve therapeutic responses. However, reproducible biomarkers predictive of a response to anti-PD-1 therapy could contribute to improving therapeutic decision-making. METHODS This retrospective study on 70 metastatic melanoma patients was undertaken to evaluate the relationships between clinical, histological, immunohistochemical and/or molecular criteria, and the 6-month objective response rate. RESULTS Better objective response rates were associated with metachronous metastases (P = 0.04), PD-L1 tumour- and/or immune-cell status (P = 0.01), CD163+ histiocytes at advancing edges (P = 0.009) of primary melanomas and NRAS mutation (P = 0.019). Moreover, CD163+ histiocytes at advancing edges (P = 0.04) were associated with longer progression-free survival (PFS), and metachronous metastases with longer overall survival (P = 0.02) and PFS (P = 0.049). CONCLUSIONS Combining these reproducible biomarkers could help improve therapeutic decision-making for patients with progressive disease.
Collapse
Affiliation(s)
- Frantz Dupuis
- Department of Pathology, Hôpital Haut-Lévêque (CHU de Bordeaux), 33604, Pessac, France
| | - Laurence Lamant
- Department of Pathology, Oncopole de Toulouse, 31100, Toulouse, France.,Université Paul-Sabatier, 31400, Toulouse, France
| | - Emilie Gerard
- Department of Dermatology, Hôpital Saint-André (CHU de Bordeaux), 33000, Bordeaux, France
| | - Nouritza Torossian
- Department of Dermatology, Paul-Sabatier-Toulouse III University (CHU de Toulouse), 31059, Toulouse, France
| | - Leonor Chaltiel
- Department of Biostatistics, Oncopole de Toulouse, 31100, Toulouse, France
| | - Thomas Filleron
- Department of Biostatistics, Oncopole de Toulouse, 31100, Toulouse, France
| | - Marie Beylot-Barry
- Department of Dermatology, Hôpital Saint-André (CHU de Bordeaux), 33000, Bordeaux, France.,INSERM U1053 Team 1 (université de Bordeaux), 33076, Bordeaux, France
| | - Caroline Dutriaux
- Department of Dermatology, Hôpital Saint-André (CHU de Bordeaux), 33000, Bordeaux, France
| | - Sorilla Prey
- Department of Dermatology, Hôpital Saint-André (CHU de Bordeaux), 33000, Bordeaux, France
| | - Audrey Gros
- INSERM U1053 Team 1 (université de Bordeaux), 33076, Bordeaux, France.,Department of Tumour Biology and Tumour Bank, Hôpital Haut-Lévêque (CHU de Bordeaux), 33604, Pessac, France
| | - Marie-Laure Jullie
- Department of Pathology, Hôpital Haut-Lévêque (CHU de Bordeaux), 33604, Pessac, France
| | - Nicolas Meyer
- Department of Dermatology, Paul-Sabatier-Toulouse III University (CHU de Toulouse), 31059, Toulouse, France
| | - Béatrice Vergier
- Department of Pathology, Hôpital Haut-Lévêque (CHU de Bordeaux), 33604, Pessac, France. .,INSERM U1053 Team 1 (université de Bordeaux), 33076, Bordeaux, France.
| |
Collapse
|
20
|
Perret RE, Jullie ML, Vergier B, Coindre JM, Le Loarer F. A subset of so-called dermal non-neural granular cell tumours are underlined by ALK
fusions, further supporting the idea that they represent a variant of epithelioid fibrous histiocytoma. Histopathology 2018; 73:532-534. [DOI: 10.1111/his.13645] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- Raul E Perret
- Department of Biopathology; Bergonié Institut; Bordeaux France
| | - Marie-Laure Jullie
- Department of Pathology; CHU Bordeaux; Hôpital Haut Lévêque; Pessac France
| | - Beatrice Vergier
- Department of Pathology; CHU Bordeaux; Hôpital Haut Lévêque; Pessac France
- University of Bordeaux; Talence France
| | - Jean-Michel Coindre
- Department of Biopathology; Bergonié Institut; Bordeaux France
- University of Bordeaux; Talence France
| | - François Le Loarer
- Department of Biopathology; Bergonié Institut; Bordeaux France
- University of Bordeaux; Talence France
| |
Collapse
|